Showing results (111-120 of 272) with videos related to
Sort By:
Pageof 28
Plos Biology|December 24, 2003
Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growthKeiichi Kondo, William Y Kim, Mirna Lechpammer, et al.Bladder Cancer (Amsterdam, Netherlands)|March 2, 2026
Computational pathology in bladder cancer: A scoping reviewMichael Superdock, Sara E Wobker, Iain Carmicheal, et al.Cancer|October 1, 2008
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experienceAtreya Dash, Joseph A Pettus, Harry W Herr, et al.European Urology|May 31, 2023
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker SelectionJoshua J Meeks, Peter C Black, Matthew Galsky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder CancerJeffrey S Damrauer, Kyle R Roell, Markia A Smith, et al.Clinical Genitourinary Cancer|May 3, 2014
Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinomaGregory R Pond, Matthew I Milowsky, Michael P Kolinsky, et al.Cancer|August 12, 2009
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinomaDavid J Gallagher, Matthew I Milowsky, Alexia Iasonos, et al.Journal of the American Chemical Society|December 13, 2016
Copper(II) Activation of Nitrite: Nitrosation of Nucleophiles and Generation of NO by ThiolsSubrata Kundu, William Y Kim, Jeffery A Bertke, et al.American Journal of Physiology. Cell Physiology|September 26, 2022
The convergence of tumor suppressors on the type I interferon pathway in clear cell renal cell carcinoma and its therapeutic implicationsLauren E Langbein, Rayan El Hajjar, William Y Kim, et al.Advanced Functional Materials|November 15, 2014
Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder CancerLei Miao, Shutao Guo, Jing Zhang, et al.Pageof 28